Memory: Can fearlessness come in a tiny package?
A molecule called microRNA-153 helps to prevent rats associating new environments with fear.
- Dartmouth College, United States
Contextual fear conditioning is a process that occurs when a painful or frightening stimulus happens within a specific context, and it can cause an individual to fear the context even when the stimulus is removed. In humans, it is thought that contextual fear conditioning can contribute to anxiety and post-traumatic stress disorder, so understanding how the brain forms “associative memories” that link a context to a traumatic event has been the subject of research for many years (Maren et al., 2013).
In rodents, we can study the neurobiological mechanisms responsible for the formation of such memories by pairing a painful stimulus with a new environment. If a rodent experiences an electrical shock after being placed in a new cage, it will associate that cage with the electrical shock. Thus, when the rodent is placed in the cage after this association has been established, it will become “frozen with fear” even if no shock is delivered.
Two regions of the brain – the amygdala and the hippocampus – have major roles in the formation of fear-associated memories. The experience of fear increases neuronal activity in several regions of the amygdala, and learning about a new environment increases activity in the hippocampus (Phillips and LeDoux, 1992). Stable associative memories are formed by changing the strength of the connections between neurons – called synapses – in these two regions.
To communicate across synapses, the presynaptic neuron releases neurotransmitters from membrane-enclosed compartments called vesicles in a process called exocytosis. The neurotransmitter molecules then travel across the synapse and bind to receptors on the surface of the postsynaptic neuron. The strength of the synapse can be changed by altering the ability of the presynaptic neuron to release neurotransmitters, or by altering the availability of the receptors on the postsynaptic neuron (Kessels and Malinow, 2009; Nicoll and Schmitz, 2005). Now, in eLife, Danesh Moazed of Harvard Medical School and colleagues – including Rebecca Mathew and Antonis Tatarakis as joint first authors – report that the synapses responsible for the formation of fear-associated memories are kept in check by a tiny molecule called microRNA-153 (Mathew et al., 2016).
MicroRNAs are short RNA molecules (Lee et al., 1993; Wightman et al., 1993) that interfere with the ability of messenger RNA molecules to encode proteins (Selbach et al., 2008). Mathew et al. – who are based at Harvard and a number of other institutes in the United States – identified a set of 21 microRNAs whose production is increased by fear conditioning in rats. In particular, they found that learning to associate fear with a new environment caused the expression of microRNA-153 to increase by a factor of approximately four in a part of the hippocampus called the dentate gyrus.
To determine whether microRNA-153 has a role in the formation of fear-associated memories Mathew et al. reduced its production in the hippocampus and performed fear conditioning experiments. They found that rats that were deficient in microRNA-153 froze more often in the cage where they had experienced an electrical shock. Thus, it appears that microRNA-153 decreases the formation of fear-associated memories.
To determine how microRNA-153 inhibits the formation of fear memories, Mathew et al. analyzed all of the genes that they had predicted would be regulated by fear-induced microRNAs. This sample included a large proportion of the genes involved in vesicle exocytosis, and microRNA-153 targeted a large number of these genes. Further investigation revealed that fear conditioning reduced the expression of the exocytosis-related genes, and microRNA-153 knockdown increased their expression.
Genes regulated by microRNA-153 (such as Snap25 and Pclo) control synaptic strength by regulating both presynaptic vesicle exocytosis and postsynaptic receptor trafficking (Jurado et al., 2013; Südhof, 2013). By demonstrating in vitro that manipulating the expression of microRNA-153 can also regulate these processes, Mathew et al. conclude that microRNA-153 counteracts the formation of associative memories during fear conditioning by decreasing the strength of synapses.
The results also lead to a number of new questions. Does microRNA-153 regulate the activity of the hippocampus more generally? And is microRNA-153 expression regulated in other brain regions, such as the amygdala, to modulate other aspects of fear?
It is also important to note that Mathew et al. found a total of 21 microRNAs whose production increased as a result of fear conditioning. Based on their sequence, these microRNAs are predicted to target genes involved in a number of processes: vesicle fusion, neuronal development, long-term potentiation, neurotransmission and synaptogenic adhesion. Thus, figuring out how these microRNAs influence memory formation is likely to involve a number of mechanisms that were not investigated by Mathew et al. Finally, as we gain insight into the roles that microRNAs play, it may be possible to leverage the properties of these tiny molecules to develop new treatments for anxiety and other disorders.
References
-
The contextual brain: implications for fear conditioning, extinction and psychopathologyNature Reviews Neuroscience 14:417–428.https://doi.org/10.1038/nrn3492
-
Synaptic plasticity at hippocampal mossy fibre synapsesNature Reviews Neuroscience 6:863–876.https://doi.org/10.1038/nrn1786
-
Differential contribution of amygdala and hippocampus to cued and contextual fear conditioningBehavioral Neuroscience 106:274–285.https://doi.org/10.1037/0735-7044.106.2.274
Article and author information
Author details
Publication history
- Version of Record published: February 6, 2017 (version 1)
Copyright
© 2017, Luikart
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 872
- views
-
- 104
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Memory: Can fearlessness come in a tiny package?
eLife 6:e24575.
https://doi.org/10.7554/eLife.24575
Further reading
-
- Cell Biology
- Neuroscience
Alternative RNA splicing is an essential and dynamic process in neuronal differentiation and synapse maturation, and dysregulation of this process has been associated with neurodegenerative diseases. Recent studies have revealed the importance of RNA-binding proteins in the regulation of neuronal splicing programs. However, the molecular mechanisms involved in the control of these splicing regulators are still unclear. Here, we show that KIS, a kinase upregulated in the developmental brain, imposes a genome-wide alteration in exon usage during neuronal differentiation in mice. KIS contains a protein-recognition domain common to spliceosomal components and phosphorylates PTBP2, counteracting the role of this splicing factor in exon exclusion. At the molecular level, phosphorylation of unstructured domains within PTBP2 causes its dissociation from two co-regulators, Matrin3 and hnRNPM, and hinders the RNA-binding capability of the complex. Furthermore, KIS and PTBP2 display strong and opposing functional interactions in synaptic spine emergence and maturation. Taken together, our data uncover a post-translational control of splicing regulators that link transcriptional and alternative exon usage programs in neuronal development.
-
- Cell Biology
Amyotrophic lateral sclerosis (ALS) is a fatal neuromuscular disorder characterized by progressive weakness of almost all skeletal muscles, whereas extraocular muscles (EOMs) are comparatively spared. While hindlimb and diaphragm muscles of end-stage SOD1G93A (G93A) mice (a familial ALS mouse model) exhibit severe denervation and depletion of Pax7+satellite cells (SCs), we found that the pool of SCs and the integrity of neuromuscular junctions (NMJs) are maintained in EOMs. In cell sorting profiles, SCs derived from hindlimb and diaphragm muscles of G93A mice exhibit denervation-related activation, whereas SCs from EOMs of G93A mice display spontaneous (non-denervation-related) activation, similar to SCs from wild-type mice. Specifically, cultured EOM SCs contain more abundant transcripts of axon guidance molecules, including Cxcl12, along with more sustainable renewability than the diaphragm and hindlimb counterparts under differentiation pressure. In neuromuscular co-culture assays, AAV-delivery of Cxcl12 to G93A-hindlimb SC-derived myotubes enhances motor neuron axon extension and innervation, recapitulating the innervation capacity of EOM SC-derived myotubes. G93A mice fed with sodium butyrate (NaBu) supplementation exhibited less NMJ loss in hindlimb and diaphragm muscles. Additionally, SCs derived from G93A hindlimb and diaphragm muscles displayed elevated expression of Cxcl12 and improved renewability following NaBu treatment in vitro. Thus, the NaBu-induced transcriptomic changes resembling the patterns of EOM SCs may contribute to the beneficial effects observed in G93A mice. More broadly, the distinct transcriptomic profile of EOM SCs may offer novel therapeutic targets to slow progressive neuromuscular functional decay in ALS and provide possible ‘response biomarkers’ in pre-clinical and clinical studies.
